Skip to main content
. 2018 Apr 22;24:2437–2445. doi: 10.12659/MSM.906210

Figure 5.

Figure 5

Average hearing threshold levels of the intravenous (IV), combined oral and IV steroid therapy (prolonged steroid therapy), and control group patients in the pre-operative period, upon activation of the cochlear implantation, at one-month follow-up and at six-month follow-up